BALTIMORE, MD July 9, 2020 - PathSensors Inc., a Baltimore biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has expanded the company's exclusive license to include clinical applications for CANARY technology. This broader license allows PathSensors to move into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY's fast and highly [...]The post PathSensors receives expanded license from MIT for CANARY Technology appeared first on PathSensors.